LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice.

Nikyar, Arash; Bolhassani, Azam; Agi, Elnaz

Nikyar, Arash; Bolhassani, Azam; Agi, Elnaz.

Affiliation

Nikyar A; Department of Molecular and Cellular Sciences, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Bolhassani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. azam.bolhassani@yahoo.com.

Biotechnol Lett ; 45(1): 33-45, 2023 Jan.

Article in En | MEDLINE | ID: mdl-36550339

Subject(s)

HIV Infections; HIV-1; Vaccines, DNA; Animals; Mice; Adjuvants, Immunologic; Antigens, Viral; DNA; HIV Infections/prevention & control; HIV-1/genetics; Human Immunodeficiency Virus Proteins; Immunity; Mice, Inbred BALB C; Vaccination; Virion; Immunoglobulin G

Key words

HIV-1; LL-37 peptide; Nef; Prime-boost strategy; Therapeutic vaccine; Vpr

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Vaccines, DNA Limits: Animals Language: En Journal: Biotechnol Lett Year: 2023 Document type: Article Affiliation country: Iran Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google